Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 19;45(1):27-30.
doi: 10.5152/tud.2018.09622. Print 2019 Nov.

The safety and efficacy of transurethral microwave therapy in high-risk catheter-dependent men

Affiliations

The safety and efficacy of transurethral microwave therapy in high-risk catheter-dependent men

Theodore R Saitz et al. Turk J Urol. .

Abstract

Objective: Previous studies have demonstrated the efficacy of transurethral microwave therapy (TUMT) in the management of high-risk catheter-dependent men, although few have assessed safety in high-risk patients, including those continuing anticoagulation therapy during treatment. Our goal was to assess the safety and effectiveness of TUMT in a population of high-risk catheter-dependent men.

Material and methods: A retrospective analysis of patients who underwent TUMT at a single Veterans Affairs facility for the treatment of benign prostatic hyperplasia was completed. The primary outcome was 30-day postprocedural complications by Clavien-Dindo grade, including bleeding events. The secondary outcome was success in catheter removal.

Results: We performed TUMT in 157 men, 105 of whom had urinary retention-requiring an indwelling urethral catheter or clean intermittent catheterization. Overall, 86% of patients underwent TUMT while on anticoagulant therapy and 25% were treated while taking warfarin. The median age of the patients was 76.9 years (95% CI 74.9-78.8) median ASA-score was 3, and median follow-up was 26 months (range 1-65). Only two men experienced hematuria requiring treatment postoperatively and no transfusions were required. Only two patients (1.9%) required readmission within 30 days after treatment. There were 24 (22.9%) Clavien-Dindo grade I-II complications without grade III or higher complications. Urinary retention resolved in 63.7% of men after treatment.

Conclusion: Our results suggest that TUMT is a safe and reasonably effective treatment for high-risk catheter-dependent men. Furthermore, the low incidence of adverse bleeding events suggests that TUMT is a safe treatment modality for men requiring uninterrupted anticoagulation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Patient overall survival and treatment failure status

References

    1. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Bonnell RF, et al. Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia. J Urol. 2011;185:1793–803. doi: 10.1016/j.juro.2011.01.074. - DOI - PubMed
    1. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur Urol. 2013;64:118–40. doi: 10.1016/j.eururo.2013.03.004. - DOI - PubMed
    1. De la Rosette J, Laguna MP, Gravas S, de Wildt MJ. Transurethral Microwave Thermotherapy: The Gold Standard for Minimally Invasive Therapies for Patients with Benign Prostatic Hyperplasia? J Endourol. 2003;4:245–51. - PubMed
    1. D’Ancona FC, van der Bij AK, Francisca EA, Kho H, Debruyne FM, Kiemeney LA, et al. Results of High-energy Transurethral Microwave Thermotherapy in Patients Categorized According to the American Socitey of Anesthesiologists Operative Risk Classification. Urology. 1999;2:322–8. doi: 10.1016/S0090-4295(98)00502-0. - DOI - PubMed
    1. Sarma AV, Jacobsen SJ, Girman CJ, Jacobson DJ, Roberts RO, Rhodes T, et al. Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men. J Urol. 2002;168:1446–52. doi: 10.1016/S0022-5347(05)64471-0. - DOI - PubMed

LinkOut - more resources